Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPE/6446 stock hub

TPE/6446 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPE/6446is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

268.7B

Taiwan Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPE/6446

In the news

Latest news · TPE/6446

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E33.9

P25 12P50 15.5P75 22.5

Trailing P/E53.3

P25 14.4P50 18P75 31.9

ROE17

P25 -16.2P50 0.3P75 9.8

ROIC51.3

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPE/6446 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

220

Groups with data

Currency

TWD

Showing 220 of 220 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	131
Enterprise value	TWD 246.9B
Exchange	Taiwan Stock Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TW0006446008
Last refreshed	2026-05-10
Market cap	TWD 268.7B
Price	TWD 724
Price currency	TWD
Rev Per Employee	119,349,442.75x
Sector	Healthcare
Sic	2836
Symbol	tpe/6446
Website	https://www.pharmaessentia.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.88%
EV Earnings	48.93x
EV/EBIT	50.14x
EV/EBITDA	46.8x
EV/FCF	73.34x
EV/Sales	15.79x
FCF yield	1.25%
Forward P/E	33.85x
P/B ratio	8.4x
P/E ratio	53.27x
P/S ratio	17.19x
PE Ratio3 Y	91.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	31.52%
EBITDA Margin	32.37%
FCF margin	21.53%
Gross margin	89.23%
Gross Profit	TWD 14B
Gross Profit Growth	63.02%
Gross Profit Growth Q	60.31%
Gross Profit Growth3 Y	88.9%
Gross Profit Growth5 Y	137.68%
Net Income	TWD 5B
Net Income Growth	70.13%
Net Income Growth Q	19.48%
Net Income Growth Quarters	11%
Net Income Growth Years	4%
Pretax Margin	31.87%
Profit Margin	32.27%
Profit Per Employee	TWD 38.5M
Profitable Years	2
ROA	9
Roa5y	-6.95
ROCE	15.06
ROE	16.97
Roe5y	-12.11
ROIC	51.34
Roic5y	-51.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	17.55%
Cagr1y	60.45%
Cagr3y	27.88%
Cagr5y	57.75%
EPS Growth	69.88
EPS Growth Q	19.27
EPS Growth Quarters	11
EPS Growth Years	4
FCF Growth	102.47%
FCF Growth Q	70.22%
OCF Growth	109.04%
OCF Growth Q	106.16%
Revenue Growth	60.61x
Revenue Growth Q	59.44x
Revenue Growth Quarters	17x
Revenue Growth Years	8x
Revenue Growth3 Y	75.71x
Revenue Growth5 Y	94.81x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.46
Assets	TWD 37.4B
Cash	TWD 22.7B
Current Assets	TWD 29B
Current Liabilities	TWD 4.7B
Debt	TWD 856M
Debt EBITDA	TWD 0.16
Debt Equity	TWD 0.03
Debt FCF	TWD 0.25
Equity	TWD 32B
Interest Coverage	193
Liabilities	TWD 5.4B
Long Term Assets	TWD 8.4B
Long Term Liabilities	TWD 755.3M
Net Cash	TWD 21.8B
Net Cash By Market Cap	TWD 8.13
Net Cash Growth	8.72%
Net Debt EBITDA	TWD -4.31
Net Debt Equity	TWD -0.68
Net Debt FCF	TWD -6.49
Tangible Book Value	TWD 31.7B
Tangible Book Value Per Share	TWD 85.52
WACC	6.62

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.2
Inventory Turnover	1.29
Net Working Capital	TWD 1.9B
Quick ratio	5.84
Working Capital	TWD 24.4B
Working Capital Turnover	TWD 0.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.13%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	TWD 1.1
Dividend Years	1
Dividend Yield	0.15%
Last Dividend	TWD 0.99
Payout Ratio	7.26%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	403.44%
1Y total return	60.39%
200-day SMA	550.8
3Y total return	109.14%
50-day SMA	655.1
50-day SMA vs 200-day SMA	50over200
5Y total return	876.48%
All Time High	780
All Time High Change	-7.18%
All Time High Date	2026-02-03
All Time Low	40.7
All Time Low Change	1,679.09%
All Time Low Date	2015-08-24
ATR	25.23
Beta	0.43
Beta1y	1.05
Beta2y	0.64
Ch YTD	54.04
High	724
High52	780
High52 Date	2026-02-03
High52ch	-7.18%
Low	668
Low52	428
Low52 Date	2025-05-23
Low52ch	69.15%
Ma50ch	10.51%
Price vs 200-day SMA	31.43%
RSI	68.81
RSI Monthly	62.01
RSI Weekly	65.57
Sharpe ratio	1.35x
Sortino ratio	2.63
Total Return	0.02%
Tr YTD	54.04
Tr1m	13.48%
Tr1w	12.25%
Tr3m	0.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 4.9B
Operating Income Growth	183.9
Operating Income Growth Q	188.4
Operating margin	31.52

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	294,397,747%
Net Borrowing	-229,309,000
Shares Insiders	8.2%
Shares Institutions	9.16%
Shares Out	371,160,000
Shares Qo Q	0.2%
Shares Yo Y	0.13%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 2.9B
Average Volume	1,875,697.8x
Bv Per Share	86.15
CAPEX	TWD -1.9B
Ch10y	388.4
Ch1m	13.48
Ch1w	12.25
Ch1y	60.05
Ch3m	0.14
Ch3y	108.7
Ch5y	862.2
Ch6m	44.51
Change	9.86%
Change From Open	8.38
Close	659
Days Gap	1.37
Depreciation Amortization	133,148,000
Dollar Volume	4,431,749,524
Earnings Date	2026-05-15
EBIT	TWD 4.9B
EBITDA	TWD 5.1B
EPS	TWD 13.59
F Score	7
FCF	TWD 3.4B
FCF EV Yield	1.36x
FCF Per Share	TWD 9.07
Financing CF	-499,926,000
Fiscal Year End	December
Founded	1,990
Graham Number	162.32125
Graham Upside	-77.58
Income Tax	TWD -62.2M
Investing CF	-2,475,125,000
Is Primary Listing	1
Last Earnings Date	2026-02-25
Last Report Date	2025-12-31
Last Split Date	2025-09-11
Last Split Type	Forward
Ma150	579.4
Ma150ch	24.96%
Ma20	648.5
Ma20ch	11.65%
Net CF	1,641,881,000
Next Earnings Date	2026-05-15
Open	668
P FCF Ratio	79.82
P OCF Ratio	50.92
Payment Date	2025-09-05
Position In Range	100
Ppne	4,901,860,000
Price Date	2026-05-08
Price EBITDA	TWD 53.09
Ptbv Ratio	8.47
Relative Volume	3.66x
Revenue	15,634,777,000x
SBC By Revenue	2.96x
Share Based Comp	463,474,000
Tax By Revenue	-0.4x
Tr6m	44.51%
Volume	6,121,201
Z Score	22.46

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPE/6446 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.2%

$1.10 annual per share

Payout ratio

+7.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+0.0%

Dividend yield + buyback yield combined

Performance

TPE/6446 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPE/6446?

Insider, institutional, and short-interest positioning.

Institutional ownership

+9.2%

Share of float held by funds and institutions

Insider ownership

+8.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

TPE/6446 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

68.8

Neutral momentum band

Price vs 200-day MA

+31.4%

50/200-day relationship not available

Beta (5Y)

0.43

Less volatile than the market

Sharpe ratio

1.35

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPE/6446

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpe/6446 stock rating?

tpe/6446 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpe/6446 analysis?

The full report lives at /stocks/tpe/6446/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpe/6446?

The latest report frames tpe/6446 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpe/6446 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.